Safety/Efficacy of AVP-923 in the Treatment of Emotional Lability (Uncontrolled Crying & Laughing) in Patients With ALS
Public ClinicalTrials.gov record NCT00021697. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Double-Blind Controlled, Multicenter Phase II/III Study to Assess the Safety and Efficacy of AVP-923 (Dextromethorphan/Quinidine) in the Treatment of Pseudobulbar Affect in Patients With Amyotrophic Lateral Sclerosis
Study identification
- NCT ID
- NCT00021697
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Avanir Pharmaceuticals
- Industry
- Enrollment
- 100 participants
Conditions and interventions
Conditions
Interventions
- AVP-923 Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 31, 2000
- Primary completion
- Mar 31, 2002
- Completion
- Mar 31, 2002
- Last update posted
- Jul 13, 2016
2001 – 2002
United States locations
- U.S. sites
- 17
- U.S. states
- 12
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Loma Linda University Dept. of Neurology | Loma Linda | California | 92354 | — |
| UCLA School of Medicine Dept. of Neurology | Los Angeles | California | 90095 | — |
| University of California, San Francisco | San Francisco | California | 94143 | — |
| University of Colorado Health Sciences | Denver | Colorado | 80262 | — |
| University of Miami Dept. of Neurology | Miami | Florida | 33136 | — |
| Northwestern Medical School | Chicago | Illinois | 60611 | — |
| Johns Hopkins University | Baltimore | Maryland | 21287 | — |
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | — |
| Columbia-Presbyterian Center Neurological Institute | New York | New York | 10032 | — |
| State University of New York | Syracuse | New York | 13210 | — |
| Carolinas Medical Center Carolinas Neuromuscular/ALS-MDA Center | Charlotte | North Carolina | 28203 | — |
| Wake Forest University | Winston-Salem | North Carolina | 27157 | — |
| Cleveland Clinic Foundation | Cleveland | Ohio | 44195 | — |
| MCP-Hahnemann University Dept. of Neurology | Philadelphia | Pennsylvania | 19107 | — |
| Penn Neurological Institute | Philadelphia | Pennsylvania | 19107 | — |
| University of Texas Health Science Center @ San Antonio | San Antonio | Texas | 78229 | — |
| University of Wisconsin ALS Clinical Research Center | Madison | Wisconsin | 53792 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00021697, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 13, 2016 · Synced May 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00021697 live on ClinicalTrials.gov.